The proposed acquisition is expected to act as a catalyst for strategic revenues while strengthening Pearsanta’s operational infrastructure and product offerings. The proposed acquisition is. | June 20, 2023
Adimune, Inc. is nearing completion of its pre-clinical package for the immunotherapy clinical study drug candidate ADI-100
Collaboration will initially target Stiff Person Syndrome, a rare,. | May 5, 2023
Aditxt, Inc., , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced the closing of its previously announced. | April 24, 2023
This agreement is a significant step for Aditxt as it expands its portfolio to include innovative therapies for infectious diseases;
Aditxt will partner with global logistics leader Agility to. | April 20, 2023
Aditxt, Inc. , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive. | April 20, 2023